Eglaf-M Tablet SR
Marketer
Arrient Healthcare Pvt Ltd
Salt Composition
Methylcobalamin (1500mcg) + Pregabalin (75mg)
Overview Eglaf-M Tablet SR
Veridia XR tablets are a prescription medication for managing neuropathic pain. They reduce pain signals by regulating calcium channel function in nerve cells. This medication also safeguards nerve fibers and aids in the repair of damaged nerve cells. Veridia XR tablets are taken orally, with or without food, ideally at bedtime. Consistent daily timing helps maintain stable drug levels. Follow your doctor's prescribed dosage and duration; this medication can be habit-forming. If a dose is missed, take it as soon as remembered. Complete the entire course of treatment, even if symptoms improve. Abruptly stopping this medication without consulting your doctor is unsafe. Common side effects include upper respiratory infection, increased hunger, elevated mood, trembling, vision blurring, dry mouth, lightheadedness, and drowsiness. Avoid driving or mentally demanding tasks until the medication's effects are known. Side effects are typically mild and subside over time. Weight gain is possible; regular exercise and a balanced diet can help manage this. Report any unusual mood or behavioral changes, new or worsening depression, or suicidal thoughts to your doctor immediately. Disclose all other medications you're using, as interactions can reduce efficacy or alter the medication's effects. Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
Primary Ingredients of Eglaf-M Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Eglaf-M Tablet SR
Managing neuropathic pain
Major Benefits of Eglaf-M Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Eglaf-M Tablet SR can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Eglaf-M Tablet SR:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Eglaf-M Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Eglaf-M Tablet SR can be consumed with or without food, though consistent timing is recommended.
How Eglaf-M Tablet SR works:
Eglaf-M SR tablets contain methylcobalamin and pregabalin, working synergistically to manage neuropathic pain. Methylcobalamin, a B vitamin derivative, supports myelin sheath production, protecting and repairing nerve fibers. Pregabalin, an alpha-2-delta calcium channel ligand, reduces pain signals by modulating nerve cell calcium influx. This dual action provides effective relief from nerve damage-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Eglaf-M sustained-release tablets and alcohol can induce significant somnolence.
PregnancyCONSULT YOUR DOCTOR
The use of Eglaf-M Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the potential benefits against these risks prior to prescribing. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Eglaf-M tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Eglaf-M Tablet SR might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Eglaf-M Tablet SR. Dosage modification for Eglaf-M Tablet SR might be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
Use of Eglaf-M Tablet SR in patients with liver impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Eglaf-M Tablet SR :
Should you forget to take a dose of Eglaf-M Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Eglaf-M Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
3,018 People bought this recently